SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-45.71M
↓ 109% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-21.83M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-45.71M | -32.0% |
| 2024 | $-34.63M | -36.8% |
| 2023 | $-25.32M | +1.2% |
| 2022 | $-25.63M | -186.1% |
| 2021 | $-8.96M | -228.5% |
| 2020 | $-2.73M | +72.2% |
| 2019 | $-9.82M | - |